Beta Blockers May Cause Depressive Symptoms
By Lori Solomon HealthDay Reporter
MONDAY, Nov. 18, 2024 -- Beta-blocker treatment can lead to a modest increase in depressive symptoms among patients who have myocardial infarction with preserved left ventricular ejection fraction (LVEF), according to a study published online Oct. 3 in the European Heart Journal: Acute CardioVascular Care.
Philip Leissner, from Uppsala University in Sweden, and colleagues investigated the effects of beta blockers on self-reported symptoms of anxiety and depression. The prespecified subanalysis included data from 806 participants in the REDUCE-AMI trial that compared beta-blocker versus no beta-blocker treatment on outcomes following myocardial infarction with preserved LVEF.
The researchers found that at baseline, 27 percent of patients had possible anxiety and 14 percent had possible depression. Beta-blocker treatment had a negative effect on depressive symptoms at two follow-up points: six to 10 weeks and 12 to 14 months (β = 0.48 and β = 0.41, respectively). However, there were no significant effects on anxiety at either follow-up point.
"Most doctors used to give beta blockers even to patients without heart failure, but as the evidence in favor of doing so is no longer so strong, this should be reconsidered," Leissner said in a statement. "We could see that some of these patients appear to be more at risk of depression. If the drug doesn't make a difference to their heart, then they are taking it unnecessarily and at risk of becoming depressed."
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
Shorter Leukocyte Telomere Length Linked to Higher Incidence of Age-Related Brain Diseases
THURSDAY, June 12, 2025 -- Individuals with shorter leukocyte telomere length (LTL) have a higher incidence of stroke, dementia, and late-life depression (LLD), individually and...
Talking Therapy Reduces Depression, Anxiety Symptoms in Stroke Survivors
THURSDAY, June 12, 2025 -- For stroke survivors, talking therapy is associated with moderate reductions in depression and large reductions in anxiety symptoms, according to a...
Almost One-Quarter of U.S. Firearm Suicides May Occur Outside the Home
WEDNESDAY, June 11, 2025 -- A growing number of firearm suicides in the United States occur outside the home, most commonly in motor vehicles, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.